Check-Cap Ltd. (CHEK)

USD 0.65

(-3.33%)

Revenue Summary of Check-Cap Ltd.

  • Check-Cap Ltd.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Check-Cap Ltd.'s latest quarterly revenue in 2023 FY was - USD , down 0.0% from previous quarter.
  • Check-Cap Ltd. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Check-Cap Ltd. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Check-Cap Ltd. reported a quarterly revenue of - USD for 2023 Q2, down 0.0% from previous quarter.
  • Check-Cap Ltd. reported a quarterly revenue of - USD for 2023 FY, down 0.0% from previous quarter.

Annual Revenue Chart of Check-Cap Ltd. (2023 - 2012)

Historical Annual Revenue of Check-Cap Ltd. (2023 - 2012)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD -100.0%
2016 244 Thousand USD 41.04%
2015 173 Thousand USD 121.95%
2014 -788 Thousand USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Revenue Comparison of Check-Cap Ltd.

Name Revenue Revenue Difference
Aspira Women's Health Inc. 9.15 Million USD 100.0%
bioAffinity Technologies, Inc. 2.53 Million USD 100.0%
Intelligent Bio Solutions Inc. 3.11 Million USD 100.0%
Standard BioTools Inc. 106.34 Million USD 100.0%
Inotiv, Inc. 572.42 Million USD 100.0%
Prenetics Global Limited 21.74 Million USD 100.0%
Neuronetics, Inc. 71.34 Million USD 100.0%
Star Equity Holdings, Inc. 45.78 Million USD 100.0%
Castle Biosciences, Inc. 219.78 Million USD 100.0%
Psychemedics Corporation 22.09 Million USD 100.0%
RadNet, Inc. 1.61 Billion USD 100.0%
Exact Sciences Corporation 2.49 Billion USD 100.0%
IDEXX Laboratories, Inc. 3.66 Billion USD 100.0%
iSpecimen Inc. 9.92 Million USD 100.0%
OpGen, Inc. 3.41 Million USD 100.0%
Exagen Inc. 52.54 Million USD 100.0%
Bionano Genomics, Inc. 36.11 Million USD 100.0%
CareDx, Inc 280.32 Million USD 100.0%
Twist Bioscience Corporation 312.97 Million USD 100.0%
Guardant Health, Inc. 563.94 Million USD 100.0%
Biodesix, Inc. 49.08 Million USD 100.0%
BioNexus Gene Lab Corp. 9.77 Million USD 100.0%
Precipio, Inc. 15.19 Million USD 100.0%
Natera, Inc. 1.08 Billion USD 100.0%
Fulgent Genetics, Inc. 289.21 Million USD 100.0%
Sera Prognostics, Inc. 306 Thousand USD 100.0%
23andMe Holding Co. 219.63 Million USD 100.0%
OPKO Health, Inc. 863.49 Million USD 100.0%
Personalis, Inc. 73.48 Million USD 100.0%
Aclaris Therapeutics, Inc. 31.24 Million USD 100.0%
Applied DNA Sciences, Inc. 13.36 Million USD 100.0%
T2 Biosystems, Inc. 7.19 Million USD 100.0%
Neogen Corporation 924.22 Million USD 100.0%
Myriad Genetics, Inc. 678.4 Million USD 100.0%
ICON Public Limited Company 8.12 Billion USD 100.0%
NeoGenomics, Inc. 591.64 Million USD 100.0%
Star Equity Holdings, Inc. 45.78 Million USD 100.0%
MDxHealth SA 70.19 Million USD 100.0%
Prenetics Global Limited 21.74 Million USD 100.0%
Illumina, Inc. 4.5 Billion USD 100.0%
DarioHealth Corp. 20.35 Million USD 100.0%
ENDRA Life Sciences Inc. - USD NaN%
Medpace Holdings, Inc. 1.88 Billion USD 100.0%
Mainz Biomed B.V. 895.47 Thousand USD 100.0%
Trinity Biotech plc 56.83 Million USD 100.0%
Sotera Health Company 1.04 Billion USD 100.0%
bioAffinity Technologies, Inc. 2.53 Million USD 100.0%